Securities Disclosure

This Securities Disclosure ("Disclosure") is provided by Phobia Solutions Inc. ("Company," "PSI," "we," "us," or "our") for informational purposes only. This Disclosure does not constitute an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction. Any offering of securities by Phobia Solutions Inc. is made only to eligible investors pursuant to applicable exemptions under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and applicable state securities laws.

This Disclosure should be read in its entirety. By accessing the content on this Site related to investment opportunities, you acknowledge that you have read, understood, and agreed to the terms set forth herein.

Phobia Solutions Inc. is conducting a private placement offering of its securities (the "Offering") pursuant to applicable exemptions from registration under the Securities Act, including but not limited to Regulation D, Rule 506(b) or 506(c), as applicable. The securities offered have not been registered under the Securities Act or any state securities laws and may not be resold or transferred without compliance with applicable laws.

The Offering is available only to persons who qualify as "accredited investors" as defined under Rule 501(a) of Regulation D promulgated under the Securities Act, or to other persons who meet the eligibility criteria established by Phobia Solutions Inc. and its legal counsel in connection with the applicable exemption being relied upon.

No federal or state securities commission or regulatory authority has approved, recommended, or disapproved of these securities or passed upon the accuracy or adequacy of this Disclosure. Any representation to the contrary is a criminal offense.

Certain statements contained on this Site and in related offering materials constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and applicable securities laws. These statements relate to future events or the future financial performance of Phobia Solutions Inc. and involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from any future results, performance, or achievements expressed or implied by such statements.

Forward-looking statements may include, without limitation: • Anticipated product launch timelines, including the projected 2027 delivery commencement • Projected revenue, market penetration, and growth figures • Statements regarding distribution agreements, patent issuance, and regulatory approvals • Statements regarding potential acquisition interest from third parties • Statements regarding the addressable market size and patient impact projections

All forward-looking statements are based on management's current expectations and assumptions. Phobia Solutions Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

An investment in Phobia Solutions Inc. involves a high degree of risk. You should carefully consider the following risks, together with all other information available to you, before making any investment decision. The risks described below are not exhaustive. Additional risks not currently known to us, or that we currently consider immaterial, may also adversely affect our business.

Early-Stage Company Risk Phobia Solutions Inc. is an early-stage company with a limited operating history. We have not yet commenced full commercial production or generated significant revenue. There is no assurance that we will achieve profitability or that our business model will prove commercially viable.

Product Development & Regulatory Risk Our products — the Phobe Fighter™ and Phobe Trainer™ — are currently in pre-production. Completion of production-ready manufacturing, regulatory compliance, and distribution agreements are subject to delays, cost overruns, and unforeseen technical challenges. No assurance can be given that required approvals or clearances, if any, will be obtained on a timely basis or at all.

Market Acceptance Risk There is no guarantee that hospitals, scan centers, physicians, or patients will adopt our products at the pace or scale we anticipate. Changing healthcare regulations, reimbursement structures, or competitive alternatives could adversely impact market penetration.

Intellectual Property Risk While Phobia Solutions Inc. has filed or intends to file patent applications for its products and methodologies, there is no guarantee that patents will be issued, or that issued patents will provide adequate protection against competitors. Third parties may challenge our IP rights or develop competing technologies.

Liquidity & Exit Risk Investments in private companies are illiquid. There is currently no public market for the securities of Phobia Solutions Inc. Investors may not be able to resell their securities for an extended period, if at all. The projected five-year exit strategy is not guaranteed, and any potential acquisition or liquidity event is speculative.

Key Person Risk The Company is substantially dependent upon the vision, experience, and leadership of its founder, Jim Gilmore. The loss of his services, or those of other key personnel, could have a material adverse effect on the Company's business and prospects.

Financing Risk The Company may require additional capital in the future to fund operations, production, marketing, and expansion. There is no assurance that such financing will be available on acceptable terms, or at all. Additional financing may result in dilution to existing investors.

The net proceeds from the private placement Offering are intended to be used for the following purposes, subject to change at management's discretion:

• Completion of production-ready manufacturing for the Phobe Fighter™ HSC, PPP, and MHDR models • Marketing, sales, and national distribution launch activities • Continuation of patent prosecution and intellectual property protection • Working capital and general corporate purposes • Delivery and placement logistics across U.S. medical markets

The actual allocation of proceeds may vary depending on the total amount raised, market conditions, and evolving business needs. Phobia Solutions Inc. reserves the right to adjust its use of proceeds as circumstances warrant.

Phobia Solutions Inc. has entered into Equity for Work Performed Contract Agreements with certain of its largest vendor partners, including firms in Birmingham, Alabama and San Francisco, California, under which those partners have elected to receive Company stock in lieu of cash compensation. The Company's corporate legal counsel has similarly elected to receive PSI stock in exchange for services rendered.

These agreements reflect the confidence of key partners in the Company's long-term value and viability. Investors should be aware that equity issued pursuant to these agreements may result in dilution to the interests of other investors.

Phobia Solutions Inc.'s current strategic exit plan is designed with a five-year horizon from the commencement of production. The Company's national distribution partner has expressed interest in a potential acquisition of Phobia Solutions Inc., subject to further discussion following the issuance of patents.

Additionally, an executive of one of the major international imaging equipment manufacturers ("Big Five") has informally indicated potential acquisition interest following a conversation with the Company's founder. These expressions of interest are preliminary and non-binding. There is no assurance that any acquisition, merger, or other liquidity event will occur or, if it does occur, that it will be on terms favorable to investors.

These disclosures are made solely for informational purposes and do not constitute a commitment or agreement of any kind.

The securities offered by Phobia Solutions Inc. have not been and will not be registered under the Securities Act or any state securities laws. They are being offered and sold in reliance upon exemptions from the registration requirements of the Securities Act and applicable state laws.

Purchasers of these securities may not resell or otherwise transfer the securities unless the securities are subsequently registered under the Securities Act and applicable state securities laws, or unless an exemption from such registration requirements is available. Investors should be prepared to hold their investment for an indefinite period.

The securities described herein are available only to persons who qualify as "accredited investors" within the meaning of Rule 501(a) of Regulation D under the Securities Act. Phobia Solutions Inc. reserves the right to require verification of accredited investor status prior to accepting any investment. Submission of investment interest through this Site does not guarantee participation in the Offering.

By expressing investment interest, you represent and warrant that you are an accredited investor, that you have sufficient knowledge and experience in financial and business matters to evaluate the merits and risks of an investment in the Company, and that you are capable of bearing the economic risk of an investment in the Company, including a total loss of your investment.

Phobia Solutions Inc. is not a registered investment adviser, broker-dealer, or financial planner. Nothing on this Site or in any related communication constitutes investment, legal, tax, or financial advice. You should consult with your own independent financial advisor, attorney, and tax professional before making any investment decision.

The information provided on this Site is believed to be accurate as of the date of publication but may change without notice. Phobia Solutions Inc. makes no representations or warranties as to the completeness, accuracy, or timeliness of any information provided.

The securities described herein may not be offered or sold in certain states without compliance with applicable state securities ("Blue Sky") laws. It is the responsibility of each prospective investor to determine whether they are legally eligible to participate in the Offering under the laws of their state of residence. Phobia Solutions Inc. does not represent that the securities are registered or qualified for sale in any particular state.

The information provided on this Site regarding the Offering is confidential and is intended solely for the use of the individual or entity to which it is addressed. Recipients are prohibited from reproducing, distributing, or disclosing the contents of this information to any third party without the prior written consent of Phobia Solutions Inc.

By accessing investment-related information on this Site, you agree to maintain the confidentiality of all non-public information provided to you in connection with the Offering.

For questions regarding the Offering, investor eligibility, or this Disclosure, please contact:

Phobia Solutions Inc. PO Box 364 Ocean Springs, MS 39566

Email: Invest@PhobiaSolutions.com General: Info@PhobiaSolutions.com Phone: 833-SOLVE-PHOBIA (+1 833-765-8374) Fax: 702-899-8454

All investment inquiries are handled with strict confidentiality in accordance with our Privacy Policy.